A Role for CCAAT/Enhancer-binding Protein in Hepatic Expression of Thrombin-activable Fibrinolysis Inhibitor
Open Access
- 1 July 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (28) , 25329-25336
- https://doi.org/10.1074/jbc.m203688200
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Characterization of the Gene Encoding Human TAFI (Thrombin-Activable Fibrinolysis Inhibitor; Plasma Procarboxypeptidase B)Biochemistry, 1999
- A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1998
- Synergistic Transactivation of HNF-1α, HNF-3, and NF-I Contributes to the Activation of the Liver-Specific Protein C GeneDNA and Cell Biology, 1997
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexPublished by Elsevier ,1996
- Characterization of the 5′-Flanking Region of the Gene for the α Chain of Human FibrinogenPublished by Elsevier ,1995
- Characterization of the IL-6 Responsive Elements in the γ Fibrinogen Gene PromoterJournal of Biological Chemistry, 1995
- Activation and Characterization of Procarboxypeptidase B from Human PlasmaBiochemistry, 1995
- Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutationNature Genetics, 1993
- Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia BNature, 1990
- An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunitsBiochemical and Biophysical Research Communications, 1989